InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Cowan Elvia, VP Senior. Insider active across 1 company, notably Vaxcyte, Inc.. Cumulatively, 16 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €271k. History available since 1 March 2023. The latest transaction was disclosed on 7 April 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Cowan Elvia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
3,000 shares@ US$25.920.0011% mcap50.0% of flowCommon StockSEC:0001960048-26-000007:0
1,487 shares@ US$55.38710.0% of flowCommon StockSEC:0001960048-26-000005:0
495 shares@ US$59.322.7% of flowCommon StockSEC:0001960048-26-000004:0
10,681 shares0Common StockSEC:0001960048-26-000002:0
4,907 shares@ US$47.89921.4% of flowCommon StockSEC:0001960048-25-000010:0
482 shares@ US$32.411.8% of flowCommon StockSEC:0001960048-25-000008:0
242 shares@ US$31.560.9% of flowCommon StockSEC:0001960048-25-000007:0
2,810 shares0Common StockSEC:0001960048-25-000006:0
5,379 shares0Common StockSEC:0001649094-25-000041:0
7,716 shares@ US$25.9226.8% of flowCommon StockSEC:0001649094-24-000124:0
5,000 shares@ US$25.9216.5% of flowCommon StockSEC:0001649094-24-000063:0
5,000 shares@ US$25.9216.8% of flowCommon StockSEC:0001649094-24-000036:0
5,000 shares@ US$25.9216.9% of flowCommon StockSEC:0001649094-24-000034:0
5,400 shares0Common StockSEC:0001415889-24-006475:0
627 shares@ US$51.004.2% of flowCommon StockSEC:0001209191-23-048468:0
7,250 shares0Common StockSEC:0001209191-23-015729:0
16 of 16 declarations
About Cowan Elvia
Elvia Cowan is SVP of Finance and CAO at Vaxcyte, Inc. She is responsible for financial management and accounting operations for the company. Elvia plays a key role in overseeing finances and strategic decision-making. Her expertise in finance contributes to the strength and growth of Vaxcyte.
